NCT00000552View on ClinicalTrials.gov

Shock Trial: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

September 30, 1994

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions

Cardiovascular DiseasesCoronary DiseaseHeart DiseasesMyocardial InfarctionMyocardial IschemiaShock, Cardiogenic

Interventions

PROCEDURE

angioplasty, transluminal, percutaneous coronary

PROCEDURE

coronary artery bypass

DRUG

thrombolytic therapy

Sponsors

Lead Sponsor

Carelon Research

All Listed Sponsors

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Carelon Research

OTHER

NCT00000552 - Shock Trial: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. | Biotech Hunter | Biotech Hunter